N/A
N=102
Reducing High School Athletes' Prescription Opioids Misuse and Diversion Through the Student Athlete Wellness Portal
Prescription Opioid Misuse
Bottom Line
View on ClinicalTrials.gov: NCT05209191 ↗Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Aug 2023
Primary outcome: Primary: Usability — 3.49 score on a scale — p=.001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Student Athlete Wellness Portal (Behavioral)
- Age
- Pediatric, Adult · 13+ yrs
- Sex
- All
- Sponsor
- Real Prevention, LLC
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Usability |
3.49 | .001 sig |
| PRIMARY Engagement |
3.50 | — |
| PRIMARY Efficacy in Resisting Offers of Opioids |
3.91 | .38 |
| PRIMARY Number of Participants Willing to Misuse Prescription Opioids |
44; 37 | .001 sig |
Summary
The goal of this study is to prevent prescription opioid misuse among high school athletes by developing, demonstrating the feasibility, and evaluating the outcomes of an innovative digital intervention.
Eligibility Criteria
Inclusion Criteria
- English-speaking male and female adolescents
- Ages 13-19
- Attending middle or high school
- Playing at last one interscholastic sport
- Parental consent
Exclusion Criteria
- No parental consent
- outside the age range
- not participating in interscholastic sports
- not in middle or high school
- participated in the Phase I research
Data sourced from ClinicalTrials.gov (NCT05209191). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.